Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_assertion type Assertion NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_head.
- NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_assertion description "[We examined the association between 36 genotyped and 193 imputed SNPs within four lipid-lowering drug target genes (HMGCR, PPARA, HM74A/GPR109A and CETP) and four non-lipid drug target genes (ACE, AGTR1, P2RY12, and ATP4B) and lipid phenotypes, blood pressure, and coronary artery disease in 5635 adult participants of the Lausanne, Switzerland, CoLaus study, genotyped using the Affymetrix 500K SNP chip technology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_provenance.
- NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_assertion evidence source_evidence_literature NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_provenance.
- NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_assertion SIO_000772 18787507 NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_provenance.
- NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_assertion wasDerivedFrom befree-2016 NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_provenance.
- NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_assertion wasGeneratedBy ECO_0000203 NP692708.RAXBsLInnhIZeKmKX7XGslb_g9hCo19mBF7MlSFc1HBtE130_provenance.